Egerton Capital (US), LP

Egerton Capital (US), LP

John Armitage launched Egerton Capital in London in 1994, later establishing a US subsidiary in New York. The firm operates as a long/short equity hedge fund manager, with the US entity registered as an investment advisor in New York. Wealth origin for the firm's capital is not publicly attributed to a single family; the firm manages capital for institutional investors and family offices. The strategy centers on fundamental, bottom-up stock selection across global equities, primarily in North America and Western Europe. Egerton holds concentrated portfolios of 30 to 50 positions, with a neutral to slightly net-long bias. Asset-class exposure is almost entirely public equities, with occasional use of derivatives for hedging. Known portfolio holdings have included technology stocks such as Microsoft and Alphabet (per public filings, 2023), as well as healthcare names like UnitedHealth Group. The firm does not maintain a venture capital or private equity arm. Egerton manages approximately $15 billion in assets (per media reports, 2024). The firm has offices in London and New York, with a total professional staff estimated at around 80 people. A notable operational event: June 2023, Egerton returned about $2 billion in capital to investors, citing limited opportunities in public markets (per Bloomberg, June 2023). The firm also operates a philanthropic foundation, the Egerton Foundation, which supports arts and education in the UK. A structural differentiator is Egerton's capacity to return capital during periods of low conviction—a discipline uncommon among hedge fund managers, who typically resist outflows. The firm has also maintained a relatively flat management fee structure (per industry reports), aligning more closely with performance-based compensation.